(ICHR) Ichor Holdings - Ratings and Ratios
Gas Delivery, Chemical Delivery, Precursor Systems, Subsystems, Valves
ICHR EPS (Earnings per Share)
ICHR Revenue
Description: ICHR Ichor Holdings
Ichor Holdings, Ltd. is a critical component supplier to the semiconductor industry, providing fluid delivery subsystems and components that are integral to the manufacturing of semiconductor devices. The companys products, including gas and chemical delivery systems, are used in various semiconductor manufacturing processes, such as etch, deposition, and chemical-mechanical planarization. Ichors capabilities extend to the manufacture of precision machined components, weldments, and other proprietary products, showcasing its expertise in the fabrication of complex components for the semiconductor equipment market. With a primary focus on serving equipment OEMs, Ichor has established itself as a key player in the semiconductor supply chain, particularly in Japan.
From a market perspective, ICHR has demonstrated a significant presence in the semiconductor materials and equipment sub-industry. The companys performance is closely tied to the demand for semiconductor manufacturing equipment, which is influenced by the overall health of the semiconductor industry. As a supplier to major semiconductor equipment manufacturers, Ichor is positioned to benefit from the ongoing advancements in semiconductor technology, including the transition to more complex and miniaturized semiconductor devices. The companys ability to adapt to the evolving needs of its customers will be crucial in driving its future growth.
Analyzing the
Based on the
ICHR Stock Overview
Market Cap in USD | 579m |
Sub-Industry | Semiconductor Materials & Equipment |
IPO / Inception | 2016-12-09 |
ICHR Stock Ratings
Growth Rating | -67.1% |
Fundamental | 30.5% |
Dividend Rating | - |
Return 12m vs S&P 500 | -49.3% |
Analyst Rating | 4.43 of 5 |
ICHR Dividends
Currently no dividends paidICHR Growth Ratios
Growth Correlation 3m | -59.5% |
Growth Correlation 12m | -77.3% |
Growth Correlation 5y | -46.5% |
CAGR 5y | -14.67% |
CAGR/Max DD 3y | -0.21 |
CAGR/Mean DD 3y | -0.71 |
Sharpe Ratio 12m | -0.53 |
Alpha | -59.09 |
Beta | 0.889 |
Volatility | 63.51% |
Current Volume | 894.9k |
Average Volume 20d | 762.8k |
Stop Loss | 16.2 (-5.1%) |
Signal | 0.16 |
Piotroski VR‑10 (Strict, 0-10) 3.0
Net Income (-20.7m TTM) > 0 and > 6% of Revenue (6% = 55.8m TTM) |
FCFTA 0.01 (>2.0%) and ΔFCFTA -4.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 32.58% (prev 39.82%; Δ -7.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.02 (>3.0%) and CFO 17.1m > Net Income -20.7m (YES >=105%, WARN >=100%) |
Net Debt (-42.9m) to EBITDA (16.6m) ratio: -2.59 <= 3.0 (WARN <= 3.5) |
Current Ratio 3.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (34.2m) change vs 12m ago 1.88% (target <= -2.0% for YES) |
Gross Margin 11.89% (prev 11.55%; Δ 0.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 96.15% (prev 84.93%; Δ 11.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio -2.52 (EBITDA TTM 16.6m / Interest Expense TTM 6.59m) >= 6 (WARN >= 3) |
Altman Z'' 3.08
(A) 0.31 = (Total Current Assets 439.1m - Total Current Liabilities 136.4m) / Total Assets 985.1m |
(B) 0.17 = Retained Earnings (Balance) 169.9m / Total Assets 985.1m |
(C) -0.02 = EBIT TTM -16.6m / Avg Total Assets 966.4m |
(D) 0.58 = Book Value of Equity 169.9m / Total Liabilities 290.9m |
Total Rating: 3.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.51
1. Piotroski 3.0pt = -2.0 |
2. FCF Yield 1.64% = 0.82 |
3. FCF Margin 1.10% = 0.28 |
4. Debt/Equity 0.20 = 2.48 |
5. Debt/Ebitda 8.22 = -2.50 |
6. ROIC - WACC -9.71% = -12.14 |
7. RoE -2.97% = -0.49 |
8. Rev. Trend -34.74% = -2.61 |
9. EPS Trend -66.59% = -3.33 |
What is the price of ICHR shares?
Over the past week, the price has changed by +1.85%, over one month by -4.90%, over three months by -4.53% and over the past year by -39.75%.
Is Ichor Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICHR is around 13.63 USD . This means that ICHR is currently overvalued and has a potential downside of -20.15%.
Is ICHR a buy, sell or hold?
- Strong Buy: 5
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ICHR price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 24.2 | 41.6% |
Analysts Target Price | 24.2 | 41.6% |
ValueRay Target Price | 15.1 | -11.6% |
Last update: 2025-09-16 04:36
ICHR Fundamental Data Overview
CCE Cash And Equivalents = 92.2m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 29.3255
P/S = 0.6232
P/B = 0.8343
P/EG = 0.4191
Beta = 1.9
Revenue TTM = 929.2m USD
EBIT TTM = -16.6m USD
EBITDA TTM = 16.6m USD
Long Term Debt = 117.5m USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 136.5m USD (Calculated: Short Term 19.0m + Long Term 117.5m)
Net Debt = -42.9m USD (from netDebt column, last quarter)
Enterprise Value = 623.4m USD (579.1m + Debt 136.5m - CCE 92.2m)
Interest Coverage Ratio = -2.52 (Ebit TTM -16.6m / Interest Expense TTM 6.59m)
FCF Yield = 1.64% (FCF TTM 10.2m / Enterprise Value 623.4m)
FCF Margin = 1.10% (FCF TTM 10.2m / Revenue TTM 929.2m)
Net Margin = -2.23% (Net Income TTM -20.7m / Revenue TTM 929.2m)
Gross Margin = 11.89% ((Revenue TTM 929.2m - Cost of Revenue TTM 818.7m) / Revenue TTM)
Tobins Q-Ratio = 3.67 (Enterprise Value 623.4m / Book Value Of Equity 169.9m)
Interest Expense / Debt = 1.20% (Interest Expense 1.64m / Debt 136.5m)
Taxrate = 21.0% (US default)
NOPAT = -16.6m (EBIT -16.6m, no tax applied on loss)
Current Ratio = 3.22 (Total Current Assets 439.1m / Total Current Liabilities 136.4m)
Debt / Equity = 0.20 (Debt 136.5m / last Quarter total Stockholder Equity 694.1m)
Debt / EBITDA = 8.22 (Net Debt -42.9m / EBITDA 16.6m)
Debt / FCF = 13.32 (Debt 136.5m / FCF TTM 10.2m)
Total Stockholder Equity = 697.5m (last 4 quarters mean)
RoA = -2.10% (Net Income -20.7m, Total Assets 985.1m )
RoE = -2.97% (Net Income TTM -20.7m / Total Stockholder Equity 697.5m)
RoCE = -2.04% (Ebit -16.6m / (Equity 697.5m + L.T.Debt 117.5m))
RoIC = -2.01% (NOPAT -16.6m / Invested Capital 825.2m)
WACC = 7.70% (E(579.1m)/V(715.6m) * Re(9.29%)) + (D(136.5m)/V(715.6m) * Rd(1.20%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 90.91 | Cagr: 1.49%
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.03% ; FCFE base≈26.9m ; Y1≈17.7m ; Y5≈8.07m
Fair Price DCF = 3.80 (DCF Value 130.4m / Shares Outstanding 34.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -66.59 | EPS CAGR: -74.01% | SUE: -1.33 | # QB: False
Revenue Correlation: -34.74 | Revenue CAGR: -13.29%
Additional Sources for ICHR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle